Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152Tb-DOTATOC-Reference-Cited by-同舟云学术

Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152Tb-DOTATOC

Published:2017 Issue:42 Volume:46 Page:14638-14646
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Baum Richard P.¹²³⁴^ORCID,Singh Aviral¹²³⁴,Benešová Martina⁵⁶⁷⁸⁹,Vermeulen Christiaan⁵⁶⁷⁸^ORCID,Gnesin Silvano¹⁰¹¹¹²⁸^ORCID,Köster Ulli¹³¹⁴¹⁵^ORCID,Johnston Karl¹⁶¹⁷⁸,Müller Dirk¹²³⁴,Senftleben Stefan¹²³⁴,Kulkarni Harshad R.¹²³⁴^ORCID,Türler Andreas¹⁸⁶⁷⁸¹⁹,Schibli Roger⁵⁶⁷⁸⁹^ORCID,Prior John O.¹⁰¹¹¹²⁸^ORCID,van der Meulen Nicholas P.⁵⁶⁷⁸¹⁸,Müller Cristina⁵⁶⁷⁸⁹^ORCID

Affiliation:

1. THERANOSTICS Centre for Molecular Radiotherapy and Molecular Imaging

2. ENETS Center of Excellence

3. Zentralklinik Bad Berka

4. Germany

5. Center for Radiopharmaceutical Sciences ETH-PSI-USZ

6. Paul Scherrer Institut

7. Villigen-PSI

8. Switzerland

9. Department of Chemistry and Applied Biosciences

10. Department of Nuclear Medicine and Molecular Imaging

11. Lausanne University Hospital

12. Lausanne

13. Institut Laue-Langevin

14. Grenoble

15. France

16. ISOLDE/CERN

17. Meyrin

18. Laboratory of Radiochemistry

19. Department of Chemistry and Biochemistry

Abstract

The existence of theragnostic pairs of radionuclides allows the preparation of radiopharmaceuticals for diagnostic and therapeutic purposes.

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2017/DT/C7DT01936J

Reference32 articles.

1. Underscoring the Influence of Inorganic Chemistry on Nuclear Imaging with Radiometals

2. Uptake kinetics of the somatostatin receptor ligand [ 86 Y]DOTA- d Phe 1 -Tyr 3 -octreotide ([ 86 Y]SMT487) using positron emission tomography in non-human primates and calculation of radiation doses of the 90 Y-labelled analogue

3. Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours

4. Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [¹⁶¹Tb]Tb-PSMA-I&T;Journal of Nuclear Medicine;2024-07-11

2. Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside;Theranostics;2024

3. From Radiochemistry of the Lanthanides to 225Ac and the Interference with Richard Baum;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024

4. Uptake of 68Ga-DOTATATE and 68Ga-DOTATOC in Primary Neuroendocrine Tumors, Metastases, and Normal Liver Tissue: Is There a Significant Difference?;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024

5. Terbium “Sisters”: More Than just a “Swiss Army Knife”;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024